[Influence of platelet aggregation inhibitors on platelet damage at prosthetic heart valves in-vitro (author's transl)].
D001241:Aspirin / Q000031:analogs & derivatives / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects; D004176:Dipyridamole / Q000494:pharmacology; D006350:Heart Valve Prosthesis; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D008239:Lysine / Q000031:analogs & derivatives / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D011422:Propionates / Q000494:pharmacology; D013442:Sulfinpyrazone / Q000494:pharmacology
D011422:Propionates; D004176:Dipyridamole; D008239:Lysine; D001241:Aspirin; C016869:tioxaprofen; D013442:Sulfinpyrazone; C010395:acetylsalicylic acid lysinate
In-vitro-Beeinflussung der Thrombozytenschädigung an künstlichen Herzklappen mit Plättchenaggregationshemmern.